Integration of hepatitis B vaccination into national immunisation programmes

BMJ

Volumn 314, Issue 7086, 1997, Pages 1033-

  Van Damme, Pierre ^a   Meheus, André ^a   Kane, Mark ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EPIDEMIOLOGICAL DATA; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; SHORT SURVEY; VACCINATION; WESTERN EUROPE; WORLD HEALTH ORGANIZATION;

COST-BENEFIT ANALYSIS; DECISION MAKING; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; NATIONAL HEALTH PROGRAMS; RISK-TAKING; TREATMENT OUTCOME; WORLD HEALTH;

EID: 0030979062     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.314.7086.1033     Document Type: Article

References (18)

1. Kane MA, Clements J, Hu D, Hepatitis B. In: Jamison DT, Mosley WH, Measham AR, Bobadilla J, eds. Disease control priorities in developing countries. New York: Oxford University Press, 1993: 321–30.
2. Kane MA. Global programme for control of hepatitis B infection. Vaccine 1995; 13(suppl 1):S47–9.
3. World Health Organisation. Expanded Programme on Immunization global advisory group. Weekly Epidemiol Record 1992; 3: 11–6.
4. Roure C. Overview of epidemiology and disease burden of hepatitis B in the European region. Vaccine 1995; 13(suppl 1):S18–21.
5. Francis DP. The public's health unprotected-reversing a decade of underutilization of hepatitis B vaccine. JAMA 1995; 274: 1242–3.
6. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990; 230: 1218–22.
7. Boxall EH. Antenatal screening for carriers of hepatitis B virus. BMJ 1995; 311: 1178–9.
8. Grosheide PM, Wladimiroff JW, Heijtinck RA, Mazel JA, Christiaens GCML, Nuijten ASM, et al. Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. BMJ 1995; 311: 1197–9.
9. Troisi CL, Hollinger FB. Overview of clinical trials in low-endemic areas. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Marcel Dekker, 1993: 179–208.
10. André F. Overview of 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990; 8(suppl):S74–8.
11. Wainwright RB, McMahon BJ, Bulkow LR, Parkinson AJ, Harpster AP, Hadler SC. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population-preliminary results of an 8 year study. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore: Williams and Wilkins, 1991: 762–6.
12. Chen DS. Hepatitis B vaccines: status report on longterm-efficacy (abstract 147). In: Proceedings of IX triennial international symposium on viral hepatitis and liver disease, Rome, April 21-25, 1996. Rome: Cp A, 1996: 41.
13. Mele A, Stroffolini T, Sagliocca L, Ricci Bitti P, Adamo B, Simonetti A, et al. Control of hepatitis B in Italy (abstract 67). In: Proceedings of IX triennial international symposium on viral hepatitis and liver disease, Rome, April 21-25, 1996. Rome: Cp A, 1996: 21.
14. Lo Monaco R, Mentore B, Rebora M, Pezzano D, Crovari P. Hepatitis B vaccination coverage and epidemiology of HBV-related disease in Liguria, Italy (abstract C282). In: Proceedings of IX triennial international symposium on viral hepatitis and liver disease, Rome, April 21-25, 1996. Rome: Cp A, 1996: 272.
15. Krahn M, Detsky AS. Should Canada and the United States universally vaccinate infants against hepatitis B? Medical Decision Making 1993; 13: 4–20.
16. Mangtani P, Hall AJ, Normand CEM. Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales. J Epidemiol Community Health 1995; 49: 238–44.
17. Van Damme P, Tormans G, Beutels P, Van Doorslaer E. Hepatitis B prevention in Europe: a preliminary economic evaluation. Vaccine 1995; 13 (suppl 1):S54–7.
18. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274: 1201–8.